27 related articles for article (PubMed ID: 3387374)
1. Prescribed drugs containing nitrogen heterocycles: an overview.
Heravi MM; Zadsirjan V
RSC Adv; 2020 Dec; 10(72):44247-44311. PubMed ID: 35557843
[TBL] [Abstract][Full Text] [Related]
2. Towards Evidence-Based Weaning: a Mechanism-Based Pharmacometric Model to Characterize Iatrogenic Withdrawal Syndrome in Critically Ill Children.
Goulooze SC; Ista E; van Dijk M; Tibboel D; Krekels EHJ; Knibbe CAJ
AAPS J; 2021 May; 23(4):71. PubMed ID: 34002290
[TBL] [Abstract][Full Text] [Related]
3. The Immediate Analgesic Effect of Acupuncture for Pain: A Systematic Review and Meta-Analysis.
Xiang A; Cheng K; Shen X; Xu P; Liu S
Evid Based Complement Alternat Med; 2017; 2017():3837194. PubMed ID: 29234385
[TBL] [Abstract][Full Text] [Related]
4. Rectal administration of nicomorphine in patients improves biological availability of morphine and its glucuronide conjugates.
Koopman-Kimenai PM; Vree TB; Booij LH; Dirksen R
Pharm World Sci; 1994 Dec; 16(6):248-53. PubMed ID: 7889023
[TBL] [Abstract][Full Text] [Related]
5. Further development of a morphine hydrogel suppository.
Cole L; Hanning CD; Robertson S; Quinn K
Br J Clin Pharmacol; 1990 Dec; 30(6):781-6. PubMed ID: 2288824
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of rectal drug administration, Part II. Clinical applications of peripherally acting drugs, and conclusions.
van Hoogdalem EJ; de Boer AG; Breimer DD
Clin Pharmacokinet; 1991 Aug; 21(2):110-28. PubMed ID: 1884566
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and efficacy of rectal versus oral sustained-release morphine in cancer patients.
Wilkinson TJ; Robinson BA; Begg EJ; Duffull SB; Ravenscroft PJ; Schneider JJ
Cancer Chemother Pharmacol; 1992; 31(3):251-4. PubMed ID: 1464164
[TBL] [Abstract][Full Text] [Related]
8. Sustained relief of chronic pain. Pharmacokinetics of sustained release morphine.
Gourlay GK
Clin Pharmacokinet; 1998 Sep; 35(3):173-90. PubMed ID: 9784932
[TBL] [Abstract][Full Text] [Related]
9. High-dose morphine and methadone in cancer patients. Clinical pharmacokinetic considerations of oral treatment.
Säwe J
Clin Pharmacokinet; 1986; 11(2):87-106. PubMed ID: 3514045
[TBL] [Abstract][Full Text] [Related]
10. The bioavailability of rectally administered morphine.
Jonsson T; Christensen CB; Jordening H; Frølund C
Pharmacol Toxicol; 1988 Apr; 62(4):203-5. PubMed ID: 3387374
[TBL] [Abstract][Full Text] [Related]
11. Comparative bioavailability of a morphine suppository given rectally and in a colostomy.
Højsted J; Rubeck-Petersen K; Rask H; Bigler D; Broen Christensen C
Eur J Clin Pharmacol; 1990; 39(1):49-50. PubMed ID: 2276388
[TBL] [Abstract][Full Text] [Related]
12. The bioavailability of morphine in controlled-release 30-mg tablets per rectum compared with immediate-release 30-mg rectal suppositories and controlled-release 30-mg oral tablets.
Kaiko RF; Fitzmartin RD; Thomas GB; Goldenheim PD
Pharmacotherapy; 1992; 12(2):107-13. PubMed ID: 1570227
[TBL] [Abstract][Full Text] [Related]
13. Absorption and bioavailability of rectally administered morphine in women.
Westerling D; Lindahl S; Andersson KE; Andersson A
Eur J Clin Pharmacol; 1982; 23(1):59-64. PubMed ID: 7128673
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
